Galectin Therapeutics Ownership | Who Owns Galectin Therapeutics?
Galectin Therapeutics Ownership Summary
Galectin Therapeutics is owned by 23.94% institutional investors, 53.08% insiders, and 22.98% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 4.54% of GALT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.31% of its assets in Galectin Therapeutics shares.
GALT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Galectin Therapeutics | 23.94% | 53.08% | 22.98% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Biotech Stocks | 379.61% | 11.70% | -291.31% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 2.99M | 4.54% | $13.87M |
| Vanguard group | 2.29M | 3.56% | $9.52M |
| Vanguard capital management | 2.17M | 3.30% | $10.06M |
| Blackrock | 1.56M | 2.52% | $3.53M |
| Geode capital management | 1.31M | 1.99% | $6.07M |
| Advisor group | 1.20M | 1.83% | $5.59M |
| Marshall wace, llp | 831.01K | 1.26% | $3.86M |
| Wealthspire advisors | 721.79K | 1.10% | $3.35M |
| State street | 567.78K | 0.86% | $2.63M |
| Commonwealth equity services | 407.11K | 0.62% | $1.89M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Retirement guys formula | 211.05K | 0.37% | $979.29K |
| Solutions 4 wealth | 25.03K | 0.15% | $116.13K |
| Vivaldi capital management lp | 258.58K | 0.10% | $721.45K |
| Sovran advisors | 258.00K | 0.07% | $874.61K |
| Argyle capital partners | 13.38K | 0.04% | $62.06K |
| Gsa capital partners llp | 128.66K | 0.04% | $597.00K |
| Geneos wealth management | 240.43K | 0.02% | $1.12M |
| Wealthspire advisors | 721.79K | 0.02% | $3.35M |
| Archer investment | 17.40K | 0.02% | $80.74K |
| Pekin hardy strauss | 30.00K | 0.01% | $139.20K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 2.99M | 0.00% | 2.19M |
| Blackrock | 1.56M | 0.00% | 851.14K |
| Geode capital management | 1.31M | 0.00% | 695.61K |
| State street | 567.78K | 0.00% | 309.35K |
| Northern trust | 386.55K | 0.00% | 256.10K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Millennium management | 35.86K | 0.00% | -762.57K |
| Marshall wace, llp | 831.01K | 0.00% | -388.90K |
| Susquehanna group, llp | 177.20K | 0.00% | -378.50K |
| Y-intercept (hong kong) | - | - | -235.19K |
| Jane street group | - | - | -194.87K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| National bank of canada /fi/ | 167.90K | 0.00% | 167.90K | $779.06K |
| Sixth street partners management company | 116.42K | 0.00% | 116.42K | $540.21K |
| Bank of new york mellon | 105.74K | 0.00% | 105.74K | $490.64K |
| Nuveen | 63.71K | 0.00% | 63.71K | $295.61K |
| Rhumbline advisers | 48.33K | 0.00% | 48.33K | $224.26K |
Sold Out
| Holder | Change |
|---|---|
| Eversource wealth advisors | -1.00 |
| True wealth design | -2.00 |
| Sbi securities | -5.00 |
| Srs capital advisors | -52.00 |
| Harbour investments | -150.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 106 | 0.95% | 15,749,022 | 13.53% | 23 | 5.38% | 55 | 5.77% | 23 | -4.17% |
| Mar 31, 2026 | 44 | -56.86% | 5,526,312 | -52.22% | 8 | 2.67% | 22 | -59.26% | 9 | -59.09% |
| Dec 31, 2025 | 69 | -22.47% | 8,887,115 | -13.85% | 13 | 5.24% | 32 | -11.11% | 17 | -37.04% |
| Sep 30, 2025 | 87 | -3.33% | 10,009,146 | -4.34% | 15 | 5.76% | 35 | -5.41% | 26 | 18.18% |
| Jun 30, 2025 | 88 | -7.37% | 9,965,158 | 0.59% | 15 | 6.42% | 36 | 24.14% | 22 | -26.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.52M | 2.31% | 170.00K |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.52M | 2.31% | 170.00K |
| Vanguard US Total Market Shares ETF | 1.25M | 1.97% | - |
| iShares Russell 2000 ETF | 1.04M | 1.58% | -18.43K |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.52M | 1.51% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 618.82K | 0.61% | 23.67K |
| iShares Russell 2000 Growth ETF | 302.35K | 0.46% | -2.77K |
| Russell 2000 Index Non-Lendable Fund | 288.97K | 0.44% | 288.97K |
| Russell 2000 Equity Index Fund B | 288.97K | 0.44% | 288.97K |
| Fidelity Extended Market Index | 274.30K | 0.42% | 2.71K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 14, 2026 | Jamil Khurram | Chief Medical Officer | Sell | $83.28K |
| Jun 29, 2026 | Shlevin Harold H. | - | Sell | $112.23K |
| Jun 26, 2026 | Shlevin Harold H. | - | Sell | $38.66K |
| Jun 26, 2026 | Jamil Khurram | Chief Medical Officer | Sell | $12.66K |
| Jun 29, 2026 | Jamil Khurram | Chief Medical Officer | Sell | $239.23K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 1 |
| 2026 Q2 | - | 6 |
| 2026 Q1 | 1 | 9 |
| 2025 Q4 | 2 | 39 |
| 2025 Q3 | 2 | 2 |
GALT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools